Traphagen Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Buy |
887
+117
| +15% | +$61.4K | 0.04% | 121 |
|
|
2025
Q1 | $488K | Buy |
770
+82
| +12% | +$52K | 0.05% | 113 |
|
|
2024
Q4 | $490K | Buy |
688
+233
| +51% | +$166K | 0.05% | 114 |
|
|
2024
Q3 | $478K | Hold |
455
| – | – | 0.05% | 109 |
|
|
2024
Q2 | $478K | Sell |
455
-290
| -39% | -$305K | 0.05% | 104 |
|
|
2024
Q1 | $718K | Sell |
745
-202
| -21% | -$195K | 0.08% | 83 |
|
|
2023
Q4 | $832K | Sell |
947
-202
| -18% | -$177K | 0.1% | 70 |
|
|
2023
Q3 | $946K | Hold |
1,149
| – | – | 0.12% | 52 |
|
|
2023
Q2 | $826K | Sell |
1,149
-2
| -0.2% | -$1.44K | 0.11% | 62 |
|
|
2023
Q1 | $946K | Buy |
1,151
+4
| +0.3% | +$3.29K | 0.14% | 54 |
|
|
2022
Q4 | $828K | Hold |
1,147
| – | – | 0.13% | 57 |
|
|
2022
Q3 | $790K | Sell |
1,147
-8
| -0.7% | -$5.51K | 0.15% | 51 |
|
|
2022
Q2 | $683K | Buy |
1,155
+6
| +0.5% | +$3.55K | 0.12% | 58 |
|
|
2022
Q1 | $802K | Hold |
1,149
| – | – | 0.13% | 50 |
|
|
2021
Q4 | $726K | Hold |
1,149
| – | – | 0.12% | 59 |
|
|
2021
Q3 | $695K | Hold |
1,149
| – | – | 0.12% | 54 |
|
|
2021
Q2 | $642K | Hold |
1,149
| – | – | 0.11% | 61 |
|
|
2021
Q1 | $544K | Buy |
1,149
+3
| +0.3% | +$1.42K | 0.1% | 71 |
|
|
2020
Q4 | $554K | Buy |
1,146
+5
| +0.4% | +$2.42K | 0.1% | 71 |
|
|
2020
Q3 | $639K | Hold |
1,141
| – | – | 0.13% | 58 |
|
|
2020
Q2 | $712K | Hold |
1,141
| – | – | 0.16% | 52 |
|
|
2020
Q1 | $557K | Sell |
1,141
-450
| -28% | -$220K | 0.15% | 56 |
|
|
2019
Q4 | $597K | Hold |
1,591
| – | – | 0.14% | 58 |
|
|
2019
Q3 | $441K | Hold |
1,591
| – | – | 0.12% | 69 |
|
|
2019
Q2 | $498K | Hold |
1,591
| – | – | 0.13% | 59 |
|
|
2019
Q1 | $653K | Buy |
+1,591
| New | +$653K | 0.18% | 46 |
|